Altshuler Shaham LTD Sarepta Therapeutics, Inc. Transaction History

Altshuler Shaham LTD

  • $1.57 Billion
  • Q3 2024

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 09, 2023
SELL
$117.53 - $155.99 $36,316 - $48,200
-309 Reduced 60.95%
198 $27,000
Q4 2022

May 09, 2023
SELL
$100.86 - $132.13 $2,622 - $3,435
-26 Reduced 4.88%
507 $65,000
Q3 2022

Nov 14, 2022
BUY
$75.71 - $119.24 $40,353 - $63,554
533 New
533 $58,000
Q3 2021

Nov 15, 2021
SELL
$65.97 - $92.48 $1,121 - $1,572
-17 Closed
0 $0
Q2 2021

Aug 16, 2021
SELL
$69.38 - $86.75 $195,859 - $244,895
-2,823 Reduced 99.4%
17 $1,000
Q1 2021

May 13, 2021
SELL
$72.25 - $168.95 $168,414 - $393,822
-2,331 Reduced 45.08%
2,840 $212,000
Q4 2020

Feb 16, 2021
SELL
$125.56 - $178.74 $502,240 - $714,960
-4,000 Reduced 43.62%
5,171 $882,000
Q3 2020

Nov 10, 2020
SELL
$127.12 - $172.34 $83,899 - $113,744
-660 Reduced 6.71%
9,171 $1.29 Million
Q1 2020

May 12, 2020
SELL
$82.38 - $131.64 $15,981 - $25,538
-194 Reduced 1.94%
9,831 $962,000
Q4 2019

Feb 11, 2020
BUY
$76.53 - $135.58 $8,800 - $15,591
115 Added 1.16%
10,025 $1.29 Million
Q3 2019

Nov 12, 2019
BUY
$72.81 - $156.91 $7,572 - $16,318
104 Added 1.06%
9,910 $755,000
Q2 2019

Aug 06, 2019
BUY
$112.21 - $151.95 $49,821 - $67,465
444 Added 4.74%
9,806 $1.49 Million
Q4 2018

Feb 11, 2019
BUY
$97.32 - $148.76 $911,109 - $1.39 Million
9,362 New
9,362 $1.02 Million

Others Institutions Holding SRPT

# of Institutions
529
Shares Held
84.2M
Call Options Held
2.06M
Put Options Held
1.52M
View Full List

About Sarepta Therapeutics, Inc.

SRPT Quotes by TradingView
  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $10.4B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Altshuler Shaham LTD Portfolio

Follow Altshuler Shaham LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Altshuler Shaham LTD, based on Form 13F filings with the SEC.

News

Stay updated on Altshuler Shaham LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email